1. It's easy enough to see if DR sold shares. Check the SEC website for form 4s.
2.I'm not the only one who posted that CTGI could easily trade under a buck without FDA approval. Right now, CTGI is a a company of great ideas. (well really one great idea that we know about). Idea-based outfits have a much more abstract and flexible value than outfits with active balance sheets. The posters here who thought that CTGI was more fairly valued at $2.30+ per share had nothing more than their strong beliefs and desires to support that idea.
3. My sell order is in at $12.50 a share. Since my initial purchase in 2005, I've had many opportunities to look back and think, "what if I had sold and bought back 2 months later?" I trade some companies, but not this one. This is scene 3 in a 20 scene blockbuster! I want to see how it's going to end.
4. I hear you on the 200k for the greased pump. But I have to cut DR some slack here as well. Looking back at all the PR activity surrounding the run to $2.39, I gotta' think that DR anticipated FDA approval to coincide with the paid pump. FDA approval at this particular time would have fetched a very handsome price for the LTC IPO. It didn't work out. That said, I'm sure DR has other ideas in the pipeline to fully capitalize on the FDA approval announcement, so that the IPO is priced as high as possible. The way I see it, if 200k can almost triple your PPS once, it can certainly be done again, especially if you have the FDA stamp of approval.
5. Nothing negative has transpired with this company. The PRs have been encouraging and show a company moving forward with their plan, controlling the factors they can control while they await the resolution of those factors that aren't in their hands.
